Our Vision

We are in a unique period of time where technology advances in all sectors can be leveraged to significantly transform healthcare. The transition from paper to digital combined with machine learning, changes the entire healthcare and life sciences landscape. Cardinal Partners’ long experience working with scientists at MIT, Stanford, Harvard, John Hopkins and Scripps Institute, provide an unfair advantage enabling us to identify promising new ideas and grow them into reality.

Engineering the flow of healthcare
By the numbers

100+

Companies Invested

$15B+

in market value

$400M

under management

25+

IPOs

30%

Consumer Sector

25%

Virtual Care

20%

Life Sciences

25%

Machine Learning/NLP/Blockchain
HOW CAN WE DELIVER MORE CARE TO MORE PEOPLE FOR LESS MONEY
— Arnie Milstein
Director, Stanford Center For Clinical Excellence Research
Venture Partner, Cardinal Partners
Investment Strategy

Understanding the complexities of the health care system is the most important step towards investment success in the sector

STAGE

Institutional financings, selective early stage rounds, opportunistic recapitalization and/or ‘re-start’ rounds

SECTOR FOCUS

Disruptive Healthcare Technology-Enabled Services, Life Sciences (Biopharmaceuticals)

ENGAGEMENT

Continuous, hands-on collaboration with each portfolio company to maximize its growth and success

EFFICIENCY

Instill and sustain financial discipline and capital efficiency throughout all growth phases of each portfolio company to fully leverage returns on investment capital
Scroll to top